Point Mutation Flanking a CTL Epitope Ablates in Vitro and in Vivo Recognition of a Full-Length Viral Protein

Journal of Immunology

Volumn 158, Issue 7, 1997, Pages 3227-3234

  Yellen Shaw, Amy J ^a   Wherry, E John ^a   Dubois, Garrett C ^a   Eisenlohr, Laurence C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; EPITOPE; MULTIENZYME COMPLEX; NUCLEOPROTEIN; PROTEASOME;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CBA MOUSE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; ENZYME SPECIFICITY; EPITOPE MAPPING; GENETICS; HUMAN; IMMUNOLOGY; L CELL; METABOLISM; MOLECULAR GENETICS; MOUSE; ORTHOMYXOVIRUS; POINT MUTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CYSTEINE ENDOPEPTIDASES; EPITOPE MAPPING; EPITOPES; HUMANS; L CELLS (CELL LINE); MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE; POINT MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; SUBSTRATE SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031114456     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.158.7.3227     Document Type: Article

References (55)

1. Zinkernagel, R. M., and P. C. Doherty. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:52.
2. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
3. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
4. Engelhard, V. H. 1994. Structure of peptides associated with class I and class II molecules. Annu. Rev. Immunol. 12:181.
5. Michalek, M. T., E. P. Grant, C. Gramm, A. L. Goldberg, and K. L. Rock. 1993. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 363:552.
6. Fehling, H. J., W. Swat, C. Laplace, R. Kühn, K. Rajewsky, U. Müller, and H. von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265:1234.
7. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761.
8. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1:533.
9. Harding, C. V., J. France, R. Song, J. M. Farah, S. Chatterjee, M. Iqbal, and R. Siman. 1995. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J. Immunol. 155:1767.
10. + T cells. Nature 364:158.
11. Snyder, H. L., J. W. Yewdell, and J. R. Bennink. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389.
12. Elliott, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
13. Heemels, M.-T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463.
14. Powis, S. J., E. V. Deverson, W. J. Coadwell, A. Ciruela, N. S. Huskisson, H. Smith, G. W. Butcher, and J. C. Howard. 1992. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 357:211.
15. Del Val, M., H.-J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145.
16. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481.
17. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:1335.
18. Bergmann, C. C., L. Tong, R. Cua, J. Sensintaffar, and S. Stohlman. 1994. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68:5309.
19. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschützky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
20. Shastri, N., T. Serwold, and F. Gonzalez. 1995. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues. J. Immunol. 155:4339.
21. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403.
22. Smith, G. L., J. Z. Levin, P. Palese, and B. Moss. 1987. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160:336.
23. Landt, O., H.-P. Grunert, and U. A. Hahn. 1990. A general method for rapid site-directed mutagenesis using the polymerase chain reaction. Gene 96:125.
24. Rötzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H.-G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252.
25. k molecule. Virology 195:851.
26. Eisenlohr, L. C., I. Bacik, J. R. Bennink, K. Bernstein, and J. W. Yewdell. 1992. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 71:963.
27. McGuire, M. J., and G. N. DeMartino. 1986. Purification and characterization of a high molecular weight proteinase (macropain) from human erythrocytes. Biochim. Biophys. Acta 873:279.
28. McGuire, M. J., M. L. McCullough, D. E. Croall, and G. N. DeMartino. 1989. The high molecular weight multicatalytic proteinase, macropain, exists in a latent form in human erythrocytes. Biochim. Biophys. Acta 995:181.
29. Taylor, P. M., J. Davey, K. Howland, J. B. Rothbard, and B. A. Askonas. 1987. Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells. Immunogenetics 26:267.
30. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
31. d. Eur. J. Immunol. 23:1776.
32. Bullock, T. N. J., and L. C. Eisenlohr. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184:1319.
33. CD8+ epitope expression. Excerpta Medica International Congress Series. In press.
34. Nuchtern, J. G., J. S. Bonifacino, W. E. Biddison, and R. D. Klausner. 1989. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 339:223.
35. Yewdell, J. W., and C. J. Hackett. 1989. Specificity and function of T lymphocytes induced by influenza A viruses. In The Influenza Viruses. R. M. Krug, ed. Plenum Publishing Corp., p. 361.
36. 1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J. Immunol. 154:511.
37. b and ovalbumin process the same peptide, SIINFEKL. Cell. Immunol. 150:447.
38. Yewdell, J. W., F. Esquivel, D. Arnold, T. Spies, L. C. Eisenlohr, and J. R. Bennink. 1993. Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter. J. Exp. Med. 177:1785.
39. Kuhlman, P., V. T. Moy, B. A. Lollo, and A. A. Brian. 1991. The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. J. Immunol. 146:1773.
40. Koup, R. A. 1994. Virus escape from CTL recognition. J. Exp. Med. 180:779.
41. Niedermann, G., G. King, S. Butz, U. Birsner, R. Grimm, J. Shabanowitz, D. F. Hunt, and D. Eichmann. 1996. The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. Proc. Natl. Acad. Sci. USA 93:8572.
42. b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69:6665.
43. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengedé, P.-M. Kloetzel, J. Neefjes, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115.
44. Dick, T. P., T. Ruppert, M. Groettrup, P. M. Kloetzel, L. Kuehn, U. H. Koszinowski, S. Stevanovic, H. Schild, and H.-G. Rammensee. 1996. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86:253.
45. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. P. Dick, H. Schild, H.-G. Rammensee, U. H. Koszinowski, and P.-M. Kloetzel. 1996. A role for the proteasome regulator PA28α in antigen presentation. Nature 381:166.
46. Falk, K., O. Rötzschke, and H.-G. Rammensee. 1990. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348:248.
47. Shepherd, J. C., T. N. M. Schumacher, P. G. Ashton-Rickardt, S. Imaeda, H. L. Ploegh, C. A. Janeway, Jr., and S. Tonegawa. 1993. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577.
48. Schumacher, T. N. M., D. V. Kantesaria, M.-T. Heemels, P. G. Ashton-Rickardt, J. C. Shepherd, K. Fruh, Y. Yang, P. A. Peterson, S. Tonegawa, and H. L. Ploegh. 1994. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J. Exp. Med. 179:533.
49. Neisig, A., J. Roelse, A. J. A. M. Sijts, F. Ossendorp, M. C. W. Feltkamp, M. Kast, C. J. M. Melief, and J. J. Neefjes. 1995. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J. Immunol. 154:1273.
50. Kobayashi, M., T. Toyoda, D. M. Adyshev, Y. Azuma, and A. Ishihama. 1994. Molecular dissection of influenza virus nucleoprotein: deletion mapping of the RNA binding domain. J. Virol. 68:8433.
51. Albo, C., A. Valencia, and A. Portela. 1995. Identification of an RNA binding region within the N-terminal third of the influenza virus nucleoprotein. J. Virol. 69:3799.
52. Moskophidis, D., and R. M. Zinkernagel. 1995. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69:2187.
53. Phillips, R. E., and A. J. McMichael. 1993. How does the HIV escape cytotoxic T cell immunity? Chem. Immunol. 56:150.
54. Johnson, R. P., and B. D. Walker. 1994. Cytotoxic T lymphocytes in human immunodeficiency virus infection: responses to structural proteins. Curr. Top. Microbiol. Immunol. 189:35.
55. Borysiewicz, L. K., and J. G. P. Sissons. 1994. Cytotoxic T cells and human herpes virus infections. Curr. Top. Microbiol. Immunol. 189:123.